pharmaphorum
AUGUST 4, 2022
Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen has swooped in with a $3.7 Currently, ANCA vasculitis is treated with rituximab combined with corticosteroids, which can have serious side effects when administered over prolonged periods.
PM360
SEPTEMBER 21, 2023
A generic here will improve access in OAB to a product with less side effects, which is especially important in the elderly population, Casberg noted. In March, the FDA approved several new naloxone products using the pathway, including one from Amphastar, which will compete with other intranasal on the market.
Contrarian Sales Techniques
FEBRUARY 10, 2023
They are designed to be safe and comfortable for patients, and typically have minimal side effects. According to various market research reports, the global non-invasive medical devices market was valued at approximately USD 45 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of over 6% from 2021 to 2028.
Expert insights. Personalized for you.
83 
Let's personalize your content